Dyslipidemias among normoglycemic members of familial NIDDM pedigrees

Mary Catherine Schumacher, Teresa M. Maxwell, Lily L. Wu, Steven Hunt, Roger R. Williams, Steven C. Elbein

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

OBJECTIVE - To examine the hypothesis that hyperinsulinemia among relatives of NIDDM probands will increase the prevalence of DLPs, we measured insulin levels and examined the frequency of DLPs among NIDDM pedigree members. RESEARCH DESIGN AND METHODS - We performed 2-h 75-g OGTTs and measured lipid and insulin levels of 287 family members and 86 spouses from 16 large Utah pedigrees ascertained for ≥2 siblings with NIDDM. RESULTS - One-hour insulin levels were higher among 206 family members with NGT than among 65 NGT spouses (483.3 vs. 361.7 pM, P = 0.05). Among the NGT family members, 32% had cholesterol levels at or above the age- and sex-specific 90th percentile level defined by the LRC studies, 33% had HDL levels ≤10th percentile, and 20% had triglyceride levels ≥90th percentile. DLP (any of the three abnormalities) was found among 58% of NGT family members, which was significantly higher than the expected 27% (P < 0.00001) and the prevalence among spouses of 45% (P < 0.05). By NCEP criteria for hyperlipidemia, 40% of family members met criteria for diet and/or pharmacological therapy. CONCLUSIONS - Normoglycemic members of NIDDM pedigrees have a high prevalence of DLPs, which approaches the prevalence in patients with NIDDM. Our data suggest that members of NIDDM pedigrees should be screened carefully for lipid abnormalities.

Original languageEnglish
Pages (from-to)1285-1289
Number of pages5
JournalDiabetes Care
Volume15
Issue number10
Publication statusPublished - Oct 1992
Externally publishedYes

Fingerprint

Pedigree
Dyslipidemias
Type 2 Diabetes Mellitus
Spouses
Insulin
Lipids
Hyperinsulinism
Glucose Tolerance Test
Hyperlipidemias
Siblings
Triglycerides
Research Design
Cholesterol
Pharmacology
Diet

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Schumacher, M. C., Maxwell, T. M., Wu, L. L., Hunt, S., Williams, R. R., & Elbein, S. C. (1992). Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. Diabetes Care, 15(10), 1285-1289.

Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. / Schumacher, Mary Catherine; Maxwell, Teresa M.; Wu, Lily L.; Hunt, Steven; Williams, Roger R.; Elbein, Steven C.

In: Diabetes Care, Vol. 15, No. 10, 10.1992, p. 1285-1289.

Research output: Contribution to journalArticle

Schumacher, MC, Maxwell, TM, Wu, LL, Hunt, S, Williams, RR & Elbein, SC 1992, 'Dyslipidemias among normoglycemic members of familial NIDDM pedigrees', Diabetes Care, vol. 15, no. 10, pp. 1285-1289.
Schumacher MC, Maxwell TM, Wu LL, Hunt S, Williams RR, Elbein SC. Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. Diabetes Care. 1992 Oct;15(10):1285-1289.
Schumacher, Mary Catherine ; Maxwell, Teresa M. ; Wu, Lily L. ; Hunt, Steven ; Williams, Roger R. ; Elbein, Steven C. / Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. In: Diabetes Care. 1992 ; Vol. 15, No. 10. pp. 1285-1289.
@article{debe2eb6f13d4208adc0c04528e03abc,
title = "Dyslipidemias among normoglycemic members of familial NIDDM pedigrees",
abstract = "OBJECTIVE - To examine the hypothesis that hyperinsulinemia among relatives of NIDDM probands will increase the prevalence of DLPs, we measured insulin levels and examined the frequency of DLPs among NIDDM pedigree members. RESEARCH DESIGN AND METHODS - We performed 2-h 75-g OGTTs and measured lipid and insulin levels of 287 family members and 86 spouses from 16 large Utah pedigrees ascertained for ≥2 siblings with NIDDM. RESULTS - One-hour insulin levels were higher among 206 family members with NGT than among 65 NGT spouses (483.3 vs. 361.7 pM, P = 0.05). Among the NGT family members, 32{\%} had cholesterol levels at or above the age- and sex-specific 90th percentile level defined by the LRC studies, 33{\%} had HDL levels ≤10th percentile, and 20{\%} had triglyceride levels ≥90th percentile. DLP (any of the three abnormalities) was found among 58{\%} of NGT family members, which was significantly higher than the expected 27{\%} (P < 0.00001) and the prevalence among spouses of 45{\%} (P < 0.05). By NCEP criteria for hyperlipidemia, 40{\%} of family members met criteria for diet and/or pharmacological therapy. CONCLUSIONS - Normoglycemic members of NIDDM pedigrees have a high prevalence of DLPs, which approaches the prevalence in patients with NIDDM. Our data suggest that members of NIDDM pedigrees should be screened carefully for lipid abnormalities.",
author = "Schumacher, {Mary Catherine} and Maxwell, {Teresa M.} and Wu, {Lily L.} and Steven Hunt and Williams, {Roger R.} and Elbein, {Steven C.}",
year = "1992",
month = "10",
language = "English",
volume = "15",
pages = "1285--1289",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "10",

}

TY - JOUR

T1 - Dyslipidemias among normoglycemic members of familial NIDDM pedigrees

AU - Schumacher, Mary Catherine

AU - Maxwell, Teresa M.

AU - Wu, Lily L.

AU - Hunt, Steven

AU - Williams, Roger R.

AU - Elbein, Steven C.

PY - 1992/10

Y1 - 1992/10

N2 - OBJECTIVE - To examine the hypothesis that hyperinsulinemia among relatives of NIDDM probands will increase the prevalence of DLPs, we measured insulin levels and examined the frequency of DLPs among NIDDM pedigree members. RESEARCH DESIGN AND METHODS - We performed 2-h 75-g OGTTs and measured lipid and insulin levels of 287 family members and 86 spouses from 16 large Utah pedigrees ascertained for ≥2 siblings with NIDDM. RESULTS - One-hour insulin levels were higher among 206 family members with NGT than among 65 NGT spouses (483.3 vs. 361.7 pM, P = 0.05). Among the NGT family members, 32% had cholesterol levels at or above the age- and sex-specific 90th percentile level defined by the LRC studies, 33% had HDL levels ≤10th percentile, and 20% had triglyceride levels ≥90th percentile. DLP (any of the three abnormalities) was found among 58% of NGT family members, which was significantly higher than the expected 27% (P < 0.00001) and the prevalence among spouses of 45% (P < 0.05). By NCEP criteria for hyperlipidemia, 40% of family members met criteria for diet and/or pharmacological therapy. CONCLUSIONS - Normoglycemic members of NIDDM pedigrees have a high prevalence of DLPs, which approaches the prevalence in patients with NIDDM. Our data suggest that members of NIDDM pedigrees should be screened carefully for lipid abnormalities.

AB - OBJECTIVE - To examine the hypothesis that hyperinsulinemia among relatives of NIDDM probands will increase the prevalence of DLPs, we measured insulin levels and examined the frequency of DLPs among NIDDM pedigree members. RESEARCH DESIGN AND METHODS - We performed 2-h 75-g OGTTs and measured lipid and insulin levels of 287 family members and 86 spouses from 16 large Utah pedigrees ascertained for ≥2 siblings with NIDDM. RESULTS - One-hour insulin levels were higher among 206 family members with NGT than among 65 NGT spouses (483.3 vs. 361.7 pM, P = 0.05). Among the NGT family members, 32% had cholesterol levels at or above the age- and sex-specific 90th percentile level defined by the LRC studies, 33% had HDL levels ≤10th percentile, and 20% had triglyceride levels ≥90th percentile. DLP (any of the three abnormalities) was found among 58% of NGT family members, which was significantly higher than the expected 27% (P < 0.00001) and the prevalence among spouses of 45% (P < 0.05). By NCEP criteria for hyperlipidemia, 40% of family members met criteria for diet and/or pharmacological therapy. CONCLUSIONS - Normoglycemic members of NIDDM pedigrees have a high prevalence of DLPs, which approaches the prevalence in patients with NIDDM. Our data suggest that members of NIDDM pedigrees should be screened carefully for lipid abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=0026705369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026705369&partnerID=8YFLogxK

M3 - Article

C2 - 1425090

AN - SCOPUS:0026705369

VL - 15

SP - 1285

EP - 1289

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 10

ER -